AVGO vs CTM
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
Broadcom exhibits a dichotomy between elite operational performance and poor deterministic value metrics. While the Piotroski F-Score of 4/9 indicates stable health, the stock trades at a massive premium to its Graham Number ($44.08) and Intrinsic Value ($151.04). This valuation gap is partially justified by a very attractive PEG ratio (0.68) and strong forward P/E (19.65), suggesting high growth expectations. However, aggressive insider selling by the CEO and CFO, combined with a bearish technical trend, offsets the strong analyst 'strong_buy' consensus.
The deterministic health profile is severely compromised, highlighted by a Piotroski F-Score of 1/9, indicating critical financial weakness. While the company maintains a strong liquidity position (Current Ratio 4.40) and positive revenue growth (21.9%), these are offset by consistent net losses and a total lack of earnings beats. Bearish technical trends and aggressive insider selling further signal a lack of confidence in the short-to-medium term outlook.
Compare Another Pair
Related Comparisons
AVGO vs CTM: Head-to-Head Comparison
This page compares Broadcom Inc. (AVGO) and Castellum, Inc. (CTM) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.